3,4-dihydro-5-methyl-1(2h)-isoquinolinone has been researched along with 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone in 1 studies
| Studies (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) | Trials (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) | Recent Studies (post-2010) (3,4-dihydro-5-methyl-1(2h)-isoquinolinone) | Studies (3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone) | Trials (3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone) | Recent Studies (post-2010) (3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone) |
|---|---|---|---|---|---|
| 16 | 0 | 2 | 37 | 0 | 15 |
| Protein | Taxonomy | 3,4-dihydro-5-methyl-1(2h)-isoquinolinone (IC50) | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone (IC50) |
|---|---|---|---|
| Poly [ADP-ribose] polymerase 2 | Mus musculus (house mouse) | 1.055 | |
| Transient receptor potential cation channel subfamily M member 2 | Homo sapiens (human) | 0.6 | |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 0.7211 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camaioni, E; Costantino, G; Macchiarulo, A; Pellicciari, R | 1 |
1 other study(ies) available for 3,4-dihydro-5-methyl-1(2h)-isoquinolinone and 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone
| Article | Year |
|---|---|
Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.
Topics: Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; Ligands; Models, Molecular; Naphthalenes; Phenanthridines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Binding; Quantitative Structure-Activity Relationship; Quinazolines | 2001 |